Bulletin
Investor Alert

CureVac N.V.

NAS: CVAC

GO
/marketstate/country/us

After Hours

/zigman2/quotes/219999729/composite

$

11.30

Change

-0.09 -0.79%

Volume

Volume 11,158

Jan 27, 2023, 7:43 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/219999729/composite

Previous close

$ 11.25

$ 11.39

Change

+0.14 +1.24%

Day low

Day high

$11.18

$11.62

Open
Open: 11.22

52 week low

52 week high

$5.63

$20.60

Open

Market cap

$2.11B

Average volume

1.06M

P/E ratio

N/A

Rev. per Employee

$121,257

EPS

-0.68

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/cvac

MarketWatch News on CVAC

  1. Super Micro, CureVac, Schwab, Roblox, and More Market Movers

    4:13 p.m. Jan. 19, 2023

    - Barron's Online

  2. CureVac upgraded to buy from neutral at UBS

    9:33 a.m. Jan. 19, 2023

    - Tomi Kilgore

  3. CureVac Stock Has Nearly Doubled in Three Days. Here's Why.

    2:21 p.m. Jan. 10, 2023

    - Barron's Online

  4. Moderna Sues Pfizer, BioNTech for mRNA Patent Infringement

    2:54 p.m. Aug. 26, 2022

    - Barron's Online

  5. Merck Jumps Into a $3.7 Billion mRNA Collaboration

    8:54 a.m. Aug. 16, 2022

    - Barron's Online

  6. Market Ends Flat on Recession Fears

    6:20 p.m. July 5, 2022

    - Barron's Online

  7. CureVac Sues BioNTech Over mRNA Technology

    4:38 p.m. July 5, 2022

    - Barron's Online

  8. Data From mRNA Cancer Treatment Look Positive, but Very Early

    9:59 a.m. April 11, 2022

    - Barron's Online

  9. Loading more headlines...
/news/nonmarketwatch/company/us/cvac

Other News on CVAC

  1. CureVac N.V. 2022 Q3 - Results - Earnings Call Presentation

    4:34 p.m. Nov. 16, 2022

    - Seeking Alpha

  2. CureVac N.V. (CVAC) Q3 2022 Earnings Call Transcript

    4:33 p.m. Nov. 16, 2022

    - Seeking Alpha

  3. Notable earnings before Wednesday's open

    11:27 a.m. Nov. 15, 2022

    - Seeking Alpha

  4. Gates Foundation added LumiraDX, pared Atreca stake in Q3

    6:17 p.m. Nov. 14, 2022

    - Seeking Alpha

  5. Bet on These 4 Biotech Stocks With Bright Prospects

    8:31 a.m. Sept. 28, 2022

    - Zacks.com

  6. Moderna Sues Pfizer and BioNTech Over mRNA Patents

    1:34 a.m. Aug. 27, 2022

    - The Wall Street Journal Interactive Edition

  7. Health Care falls 2.8% in June, Nutex, CureVac biggest losers

    11:23 a.m. July 1, 2022

    - Seeking Alpha

  8. CureVac acquiring Frame Cancer Therapeutics for €32 million

    4:18 p.m. June 8, 2022

    - Seeking Alpha

  9. Loading more headlines...
/news/pressrelease/company/us/cvac

Press Releases on CVAC

  1. Thursday's ETF with Unusual Volume: IDNA

    10:20 a.m. Nov. 17, 2022

    - MarketNewsVideo.com

  2. Loading more headlines...

Rates »

Link to MarketWatch's Slice.